|
|
books
| book details |
Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers: A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview
Edited by Mukesh Nandave
|
| on special |
normal price: R 5 665.95
Price: R 5 099.95
|
| book description |
This book delves into the various aspects of the renin-angiotensin-aldosterone system (RAAS) and its role in cardiovascular disorders. It explores the use of anti-hypertensive agents, with a focus on (ACE) angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (ARBs). The chapters cover topics such as the preferred use of ACE inhibitors over ARBs in high-risk patients, the impact of these agents on insulin resistance, their role in acute heart failure and peripheral artery disease, and their immunomodulatory activity in hypertensive patients. Additionally, the book examines the role of ACE inhibitors and ARBs in COVID-19 patients and provides insights into recent trends in managing hypertension through RAAS inhibition. It serves as a valuable resource for researchers, clinicians, and healthcare professionals involved in the field of cardiovascular medicine.
| product details |
Normally shipped |
Publisher | Springer Verlag, Singapore
Published date | 27 Oct 2024
Language |
Format | Hardback
Pages | 602
Dimensions | 235 x 155 x 0mm (L x W x H)
Weight | 0g
ISBN | 978-9-8197-7379-4
Readership Age |
BISAC | medical / pharmacology
| other options |
Normally shipped |
Readership Age |
Normal Price | R 7 859.95
Price | R 7 073.95
| on special |
|
|
To view the items in your trolley please sign in.
| sign in |
|
|
|
| specials |
|
|
|
Matt Dinniman
Paperback / softback
480 pages
was: R 523.95
now: R 461.95
|
|
|
An epic love story with the pulse of a thriller that asks: what would you risk for a second chance at first love?
|
|
|
|
